RNA-based nanomedicines and their clinical applications

首页 > 成果 > 详情

认领

导出

Link by 万方学术期刊

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Su, Lin-Jia;Ji, Zi-Han;Xu, Mo-Xi;Zhu, Jia-Qing;Chen, Yi-Hai;...

通讯作者：

Wang, Yi;Lin, YX;Wang, Y

作者机构：

[Wang, Yi; Ji, Zi-Han; Wang, Y; Qiao, Jun-Fei; Lin, YX; Xu, Mo-Xi; Lin, Yao-Xin; Su, Lin-Jia; Chen, Yi-Hai; Zhu, Jia-Qing] Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.

[Ji, Zi-Han; Lin, YX; Xu, Mo-Xi; Lin, Yao-Xin] Univ Chinese Acad Sci UCAS, Beijing 100149, Peoples R China.

[Chen, Yi-Hai] Harbin Med Univ, Dept Breast Surg, Canc Hosp, Harbin 150081, Peoples R China.

[Qiao, Jun-Fei] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China.

[Wang, Yi; Wang, Y] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, CH-1015 Lausanne, Switzerland.

通讯机构：

[Wang, Y; Lin, YX ] N

[Wang, Y ] E

Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.

Univ Chinese Acad Sci UCAS, Beijing 100149, Peoples R China.

Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, CH-1015 Lausanne, Switzerland.

语种：

英文

关键词：

RNA-based nanomedicine;conjugate-based delivery system;nanoparticle-based delivery system;clinical trial

期刊：

纳米研究：英文版

ISSN：

1998-0124

年：

2023

卷：

期：

页码：

13182-13204

DOI：

10.1007/s12274-023-6238-5

基金类别：

National Natural Science Foundation of China [32371458]; Key Research and Development Programs of the Ministry of Science and Technology [2022YFA1205700]; Basic Research Cooperation Special Foundation of Beijing-Tianjin-Hebei [H2022205047, 22JCZXJC00060, E3B33911DF]; National Center for Nanoscience and Technology and Chinese Academy of Sciences

机构署名：

本校为其他机构

院系归属：

化学与环境工程学院

摘要：

RNA-based nanomedicines encompass a range of therapeutic approaches that utilize RNA molecules or molecules that target RNAs for the treatment or prevention of diseases. These include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), endogenous microRNAs (miRNAs), messenger RNAs (mRNAs), clustered regularly interspersed short palindromic repeats-associated protein 9 (CRISPR/Cas9), single guide RNAs (sgRNAs), as well as RNA aptamers. These therapeutic agents exert their effects through various mechanisms such as gene inhibition, addition, replacement, and editing. The advancem...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

RNA-based nanomedicines and their clinical applications

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问